Faculty Information - 羽井佐　実 |

（Last updated : 2021-07-28 16:03:56）

羽井佐　実
Department ,

Position

■ Journal

1.	2017/11		Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.
2.	2017/10		Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.
3.	2017/04		False-Positive Cases of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomographic Scans in Metastasis of Esophageal Cancer
4.	2017/02		A Case of Cholesterol Crystal Embolization with Hemorrhagic Imntestinal Ulcer
5.	2017/02		Evaluation of intra-ductal cancer spread using contrast superb micro-vascular imaging(SMI)-a case report-
6.	2016/02		SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
7.	2015/06		Skin Tube Reconstruction for Esophageal Defects due to Postoperative Complications: Applying a skin flap in esophageal resection and reconstruction
8.	2015/05		Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest
9.	2014/12		A case report of isolated presacral squamous cell carcinoma developd four years after gastrectomy
10.	2014/12		Amino acid signaling in the intestine: The roles of glutamine, leucine and arginine
11.	2013/04		The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer.
Display 5 items
Display all(11)

■ Presentation

1.	2018/09/28	Targeted silencing of SOX2 by an ATF showed antitumor effect in lung and esophageal squamous cell carcinoma
2.	2018/09/16	False positive cases of FDG-PET/CT in metastasis of esophageal squamous cell carcinoma
3.	2018/06/08	A surgical case of jejunal aberrant pancreas containing high-grade pancreatic intraepithelial neoplasia(PanIN3)
4.	2018/04/16	Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma
5.	2017/06/09	A surgical case of metachronous liver metastasis of hepatoid adenocarcinoma of the stomach
6.	2017/04/03	Development of a novel targeted therapy for malignant mesothelioma carcinoma by a midkine inhibitor.
7.	2016/10/06	SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
8.	2016/04/18	Sox2 silencing upregulates CDKNIA and suppresses growth of lung squamous cell carcinoma
9.	2015/04/21	Developmemt of a Sox2 targeting therapy for the treatment of lung squamous cell carcinoma
10.	2015/04/20	Esphageal cancer exhibits a resistance to the chemical of IGF-1R with a maintained Ras-MAPK activity
11.	2014/09/27	Sox2 silencing suppresses cell growth and colony formation of squamous cell lung cancer
12.	2014/04/06	Effective use of MDK/Midkine and MEK inhibitor to treat KRas mutated pulmonary adenocarcinoma cells
13.	2014/04/04	Inhibition of the growth factor midkine by a novel small molecule compound to treat pulmonary adenocarcinoma
14.	2010/09/01	Analysis of Surgically Resected Case of Barrett's ESophageal Carcinoma.
15.	2010/04/19	N-cadherin down-rgulation has antitumor effects in esophageal cancer
Display 5 items
Display all(15)